VANGUARD GROUP INC - PLIANT THERAPEUTICS INC ownership

PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 93 filers reported holding PLIANT THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of PLIANT THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$36,949,470
-28.7%
3,437,160
-1.2%
0.00%0.0%
Q1 2024$51,827,489
-6.7%
3,478,355
+13.5%
0.00%0.0%
Q4 2023$55,522,888
+8.7%
3,065,869
+4.1%
0.00%0.0%
Q3 2023$51,071,710
+1.5%
2,945,312
+6.1%
0.00%0.0%
Q2 2023$50,316,667
-20.3%
2,776,858
+17.0%
0.00%
-50.0%
Q1 2023$63,114,405
+67.5%
2,372,722
+21.7%
0.00%
+100.0%
Q4 2022$37,675,021
+12.8%
1,949,044
+21.9%
0.00%0.0%
Q3 2022$33,410,000
+296.2%
1,599,324
+51.9%
0.00%
Q2 2022$8,433,000
-2.4%
1,052,686
-14.6%
0.00%
Q1 2022$8,642,000
-47.5%
1,232,699
+1.2%
0.00%
Q4 2021$16,449,000
-31.3%
1,218,410
-14.1%
0.00%
-100.0%
Q3 2021$23,946,000
-35.3%
1,418,599
+11.6%
0.00%0.0%
Q2 2021$37,030,000
-14.6%
1,271,656
+15.3%
0.00%0.0%
Q1 2021$43,369,000
+276.6%
1,102,685
+117.5%
0.00%
Q4 2020$11,517,000
+15.3%
506,959
+15.0%
0.00%
Q3 2020$9,988,000
+1130.0%
440,993
+1664.0%
0.00%
Q2 2020$812,00025,0000.00%
Other shareholders
PLIANT THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Mass General Brigham, Inc 288,690$3,103,41815.11%
TRV GP IV, LLC 2,132,867$22,928,32011.34%
Blue Owl Capital Holdings LP 3,004,199$32,295,1398.98%
GREAT POINT PARTNERS LLC 2,636,864$28,346,2885.43%
First Light Asset Management, LLC 3,401,213$36,563,0403.20%
Redmile Group, LLC 3,209,591$34,503,1032.09%
Deep Track Capital, LP 5,972,257$64,201,7631.92%
Fernwood Investment Management, LLC 496,286$5,335,0751.66%
Checkpoint Capital L.P. 232,200$2,496,1501.50%
Exome Asset Management LLC 124,000$1,333,0001.16%
View complete list of PLIANT THERAPEUTICS INC shareholders